Natixis Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Buy |
72,143
+9,153
| +15% | +$199K | ﹤0.01% | 1164 |
|
|
2025
Q1 | $1.53M | Buy |
62,990
+3,737
| +6% | +$90.7K | ﹤0.01% | 1161 |
|
|
2024
Q4 | $1.24M | Buy |
59,253
+13,616
| +30% | +$284K | ﹤0.01% | 1243 |
|
|
2024
Q3 | $907K | Buy |
45,637
+12,491
| +38% | +$248K | ﹤0.01% | 1323 |
|
|
2024
Q2 | $513K | Buy |
+33,146
| New | +$513K | ﹤0.01% | 1429 |
|
|
2024
Q1 | – | Sell |
-12,097
| Closed | -$203K | – | 1536 |
|
|
2023
Q4 | $203K | Buy |
+12,097
| New | +$203K | ﹤0.01% | 1516 |
|
|
2023
Q1 | – | Sell |
-15,367
| Closed | -$286K | – | 1470 |
|
|
2022
Q4 | $286K | Buy |
+15,367
| New | +$286K | ﹤0.01% | 1403 |
|